All

4 November 2021

Cytoki

Developing novel therapeutics which target epithelial cell repair and regeneration as a key therapeutic axis for maintaining homeostasis of the microbiome and the immune...

27 December 2016

Fluxome

Fluxome produces pure and natural resveratrol with ingredients that give beneficial effects to human health.
The compaby xas acquired by Evolva on November 29, 2012.

15 November 2018

Galecto Biotech

Galecto is focused on developing novel drugs for the treatment of fibrosis, inflammation, and other serious human diseases. The company’s products target galectins or...

8 November 2016

Santaris Pharma

Santaris Pharma A/S uses its proprietary Locked Nucleic Acid (LNA) platform and tissue-targeting expertise to pioneer next-generation antisense product candidates. Santaris...

27 December 2016

Vivostat

Vivostat® is the world’s only system for on-site preparation of autologous Platelet Rich Fibrin (PRF®) and fibrin sealant. It provides a range of safe, versatile and...

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse